Accuray Radixact System with Synchrony Technology Delivers Advanced Cancer Treatments

Pic by marijana1 on pixabay

Accuray Incorporated states multiple sites in Japan are now using the Radixact System with Synchrony, including Takarazuka City Hospital in Hyogo, Japanese Red Cross Nagoya Daini Hospital in Aichi, and Kishiwada Tokushukai Hospital in Osaka. The Synchrony technology will enable the hospital teams to treat a wider range of cancer cases, faster and with less harm to patients.

Chikao Sugie, MD, Vice Director – Department of Radiology, Japanese Red Cross Nagoya Daini Hospital said: “Using the Radixact System with Synchrony real-time tracking technology, SBRT at our hospital can be performed more effectively in the lower lobes of the lung. Synchrony enables us to reduce radiation exposure to healthy lung tissues in the lower lobe because we no longer have to expand the treatment field to encompass the entire volume of tumor movement. I can confidently recommend Radixact with Synchrony to our patients. The introduction of the Radixact System with Synchrony allows us to decrease the irradiated lung volume, making the treatment less stressful and invasive for patients, while also reducing the procedural burden on our healthcare team. In the future, I would like to expand the indications for treatment using this technology to include liver SBRT, based on our positive experience with lung SBRT and boost irradiation of advanced lung tumors. Synchrony technology has increased the versatility of the system and achieved automated, ultra-precise radiation therapy, which brings exceptional value to us.”

Suzanne Winter, Chief Commercial Officer and Senior Vice President, R&D, Accuray said: “We are very encouraged by the early adoption of our Synchrony and Radixact System technologies by customers in Japan, the country currently with the highest penetration of these innovative solutions in the world. We are proud to have the opportunity to partner with such enthusiastic clinical professionals to advance cancer care in Japan. Cancer is highly prevalent in the aging Japanese population. Synchrony for the Radixact System will provide clinicians with the technology they need to effectively and efficiently treat virtually any patient requiring radiation therapy. The combined technologies enable the delivery of radiation using a variety of methods — from image-guided intensity-modulated radiation therapy (IG-IMRT) to stereotactic body radiation therapy (SBRT) — to treat almost any tumor, even those that move, with precision, accuracy and unprecedented flexibility.”